8-K: Greenwave Technology Solutions Secures $15.3 Million in Registered Direct Offering and Private Placement

Greenwave Technology Solutions has raised approximately $15.3 million through a registered direct offering of common stock and a concurrent private placement of warrants.

Summary

• Greenwave Technology Solutions, Inc. has entered into a securities purchase agreement with institutional and accredited investors.
• The company will sell 5,044,885 shares of common stock in a registered direct offering.
• Accompanying warrants to purchase up to 5,044,885 shares of common stock will be issued in a concurrent private placement.
• The gross proceeds from the offering are approximately $15.3 million, before deducting fees and expenses.
• The purchase price per share and accompanying warrant is $3.035.
• The warrants are immediately exercisable with an exercise price of $2.91 per share and expire five years from the issuance date.
• The warrants can be exercised on a cashless basis after 120 days if there is no effective registration statement for resale of the warrant shares.
• An alternative cashless exercise is available after stockholder approval, where holders receive 0.75 of the shares they would have received in a cash exercise.
• The company intends to use the net proceeds for debt satisfaction and working capital.
• The offering is expected to close on or about June 12, 2024.

Sentiment

Score: 7

Explanation: The document indicates a positive development for the company as it secures funding, but the potential for dilution and the costs associated with the offering temper the overall sentiment. The use of proceeds for debt repayment is a positive sign.

Positives

• The company has successfully secured a significant capital injection of $15.3 million.
• The warrants provide flexibility with both standard and cashless exercise options.
• The funds will be used to reduce debt and improve working capital.
• The offering includes a mechanism for alternative cashless exercise after stockholder approval, potentially increasing investor interest.
• The company has a clear plan for the use of proceeds.

Negatives

• The warrants are immediately exercisable, which could lead to potential dilution of existing shares.
• The cashless exercise option is contingent on the absence of an effective registration statement or prospectus for resale of the warrant shares.
• The alternative cashless exercise reduces the number of shares received by 25% compared to a cash exercise.
• The company will incur significant fees and expenses related to the offering, including a 6% cash fee to the placement agent.

Risks

• The company's ability to use the net proceeds effectively for debt satisfaction and working capital is crucial.
• The cashless exercise of warrants could lead to further dilution of existing shares if a registration statement is not in place.
• The company's stock price could be affected by the issuance of new shares and the potential exercise of warrants.
• The company is reliant on obtaining stockholder approval for the alternative cashless exercise.
• The company is subject to market risks and general economic conditions.

Future Outlook

The company intends to use the net proceeds from the offering for debt satisfaction and working capital purposes. The company also plans to file a registration statement for the resale of the warrant shares within 20 calendar days and use commercially reasonable efforts to have it declared effective within 120 days.

Industry Context

This capital raise is a common strategy for companies to secure funding for operations, debt repayment, and growth initiatives. The use of warrants is a typical incentive for investors in such offerings, and the cashless exercise options provide flexibility for both the company and investors.

Comparison to Industry Standards

• The structure of this offering, combining a registered direct offering with a concurrent private placement of warrants, is a fairly standard approach for small to mid-cap companies seeking capital.
• The warrant exercise price of $2.91 is below the purchase price of $3.035, which is a common incentive to encourage warrant exercise.
• The 6% cash fee to the placement agent is within the typical range for such transactions.
• The inclusion of cashless exercise options is a common feature in warrants, providing flexibility for investors.
• The timeline for filing a registration statement for resale of warrant shares (20 days) and achieving effectiveness (120 days) is also typical.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares and potential exercise of warrants.
• Employees may benefit from improved financial stability and working capital.
• Creditors may benefit from the company's debt repayment.
• Customers and suppliers may see improved business operations due to the company's improved financial position.

Next Steps

• The company will close the offering on or about June 12, 2024.
• The company will file a registration statement for the resale of the warrant shares within 20 calendar days.
• The company will use commercially reasonable efforts to have the registration statement declared effective within 120 days.
• The company will seek stockholder approval for the alternative cashless exercise of warrants.
• The company will apply to list the shares and warrant shares on the Nasdaq Capital Market.

Key Dates

Keywords

registered direct offering, private placement, common stock, warrants, capital raise, debt repayment, working capital, cashless exercise, stock dilution, Dawson James Securities